Literature DB >> 26459977

Ecthyma Gangrenosum-Like Lesions Secondary to Methicillin-Sensitive Staphylococcus aureus in an Immunocompetent Child.

Silvia S Song1,2, Catalina Matiz1,3, Wynnis L Tom1,3, Antoanella Calame3,4, Andrew C Krakowski1,3, Sheila F Friedlander1,3.   

Abstract

We describe a previously healthy 15-month-old girl who developed ecthyma gangrenosum (EG)-like lesions secondary to methicillin-sensitive Staphylococcus aureus (MSSA). Her systemic symptoms and negative blood cultures suggested MSSA toxin-mediated effects. When toxin-mediated systemic symptoms accompany such lesions, pathogens other than Pseudomonas aeruginosa should be considered.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26459977     DOI: 10.1111/pde.12699

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

1.  Ecthyma gangrenosum secondary to methicillin-sensitive Staphylococcus aureus.

Authors:  Jurate Ivanaviciene; Lisa Chirch; Jane M Grant-Kels; Philip E Kerr; Justin Finch
Journal:  Int J Womens Dermatol       Date:  2016-07-22

2.  Ecthyma Gangrenosum Secondary to Methicillin-Sensitive Staphylococcus aureus in an Atopic Child with Transient Neutropenia: A Case Report and Review of the Literature.

Authors:  Ko-Chun Fang; Fang-Ju Lin; Chih-Ho Chen; Yi-Ning Huang; Jui Lan; Han-Chi Tseng; Yi-Chuan Huang
Journal:  Diagnostics (Basel)       Date:  2022-07-11

Review 3.  Ecthyma gangrenosum caused by Staphylococcus aureus in hematological malignancies: Case reports and literature review.

Authors:  Yuka Kudo Nagata; Noritaka Sekiya; Kazuaki Fukushima; Masao Horiuchi; Noriko Doki
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

4.  Ecthyma gangrenosum and severe neutropenic sepsis caused by Staphylococcus aureus infection in a previously healthy child: a case report.

Authors:  Xinjuan Zhang; Yanping Yu
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.